"Never Events": Not Every Hospital-Acquired Infection Is Preventable

被引:60
作者
Brown, Jack [1 ,2 ,3 ]
Doloresco, Fred, III [1 ,3 ,6 ]
Mylotte, Joseph M. [4 ,5 ]
机构
[1] SUNY Buffalo, Dept Pharm Practice, Sch Pharm & Pharmaceut Sci, Buffalo, NY 14260 USA
[2] Univ Rochester, Med Ctr, Dept Pharm, Rochester, NY 14642 USA
[3] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Social & Prevent Med, Buffalo, NY 14260 USA
[4] SUNY Buffalo, Sch Med & Biomed Sci, Dept Med, Buffalo, NY 14260 USA
[5] SUNY Buffalo, Sch Med & Biomed Sci, Dept Microbiol, Buffalo, NY 14260 USA
[6] Erie Cty Med Ctr & Labs, Dept Pharm, Buffalo, NY USA
关键词
D O I
10.1086/604719
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Medicare stopped reimbursing United States hospitals for several complications or comorbidities developed during hospitalizations effective 1 October 2008. The Centers for Medicare and Medicaid Services selected high-cost or high-frequency events from the National Quality Forum's list of "never events" for inclusion in this reimbursement change. Several of these complications and/or comorbidities are nosocomial infections, a significant proportion of which are not likely to be preventable. Attempts to eliminate these events may have unwanted clinical and economic outcomes, and compliance with coding and billing requirements will have a significant effect on research conducted using administrative databases. Although this reimbursement change is a step toward reducing the rate of preventable adverse events, its current form does not provide guidance with regard to how hospitals may hope to reduce the rate of these infections, and it uses individual case-based rather than process-based or population-based outcome measures, which makes benchmarking and goalsetting difficult.
引用
收藏
页码:743 / 746
页数:4
相关论文
共 10 条
[1]  
Centers for Medicare and Medicaid Services (CMS) HHS, 2008, Fed Regist, V73, P48433
[2]  
*DEP HLTH HUM SERV, EL SER PREV COSTL ME
[3]  
Department of Health and Human Services Action Plan to Prevent Health-care-Associated Infections, ACT PLAN PREV HEALTH
[4]  
Foxman B, 2002, AM J MED, V113, p5S
[5]   Nosocomial Infection, the Deficit Reduction Act, and incentives for hospitals [J].
Graves, Nicholas ;
McGowan, John E., Jr. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (13) :1577-1579
[6]   The preventable proportion of nosocomial infections: an overview of published reports [J].
Harbarth, S ;
Sax, H ;
Gastmeier, P .
JOURNAL OF HOSPITAL INFECTION, 2003, 54 (04) :258-266
[7]   Association of timely administration of prophylactic antibiotics for major surgical procedures and surgical site infection [J].
Hawn, Mary T. ;
Itani, Kamal M. ;
Gray, Stephen H. ;
Vick, Catherine C. ;
Henderson, William ;
Holiston, Thomas K. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2008, 206 (05) :814-821
[8]   Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates [J].
Johnson, Luke ;
Sabel, Allison ;
Burman, William J. ;
Everhart, Rachel M. ;
Rome, Marcie ;
MacKenzie, Thomas D. ;
Rozwadowski, Jeanne ;
Mehler, Philip S. ;
Price, Connie Savor .
AMERICAN JOURNAL OF MEDICINE, 2008, 121 (10) :876-884
[9]   Cost of intensive care unit-acquired bloodstream infections [J].
Laupland, K. B. ;
Lee, H. ;
Gregson, D. B. ;
Manns, B. J. .
JOURNAL OF HOSPITAL INFECTION, 2006, 63 (02) :124-132
[10]   Collateral damage from cephalosporin or quinolone antibiotic therapy [J].
Paterson, DL .
CLINICAL INFECTIOUS DISEASES, 2004, 38 :S341-S345